These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22001602)

  • 1. Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.
    Mori T; Nishizawa S; Hirohashi Y; Torigoe T; Tamura Y; Takahashi A; Kochin V; Fujii R; Kondo T; Greene MI; Hara I; Sato N
    Exp Mol Pathol; 2012 Feb; 92(1):27-32. PubMed ID: 22001602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
    Takaya A; Hirohashi Y; Murai A; Morita R; Saijo H; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Takemasa I; Kondo T; Sato N; Torigoe T
    PLoS One; 2016; 11(7):e0158903. PubMed ID: 27415781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
    Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
    Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.
    Yamada R; Takahashi A; Torigoe T; Morita R; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Watarai K; Kondo T; Hirohashi Y; Sato N
    Tissue Antigens; 2013 Jun; 81(6):428-34. PubMed ID: 23574628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
    Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
    Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.
    Morita R; Nishizawa S; Torigoe T; Takahashi A; Tamura Y; Tsukahara T; Kanaseki T; Sokolovskaya A; Kochin V; Kondo T; Hashino S; Asaka M; Hara I; Hirohashi Y; Sato N
    Cancer Sci; 2014 Apr; 105(4):389-95. PubMed ID: 24450541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antitumor immunity using dendritic cells electroporated with Polo-like kinase 1 (Plk1) mRNA in murine tumor models.
    Park JS; Sohn HJ; Park GS; Chung YJ; Kim TG
    Cancer Sci; 2011 Aug; 102(8):1448-54. PubMed ID: 21545375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adoptive T cell immunotherapy targeting cancer stem cells in a colon cancer model.
    Gao XY; Wang XL
    J BUON; 2015; 20(6):1456-63. PubMed ID: 26854441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
    Morita R; Hirohashi Y; Torigoe T; Ito-Inoda S; Takahashi A; Mariya T; Asanuma H; Tamura Y; Tsukahara T; Kanaseki T; Kubo T; Kutomi G; Mizuguchi T; Terui T; Ishitani K; Hashino S; Kondo T; Minagawa N; Takahashi N; Taketomi A; Todo S; Asaka M; Sato N
    Clin Cancer Res; 2016 Jul; 22(13):3298-309. PubMed ID: 26861454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.
    Yasuda K; Hirohashi Y; Mariya T; Murai A; Tabuchi Y; Kuroda T; Kusumoto H; Takaya A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Hirano H; Hasegawa T; Saito T; Sato N; Torigoe T
    Oncotarget; 2017 May; 8(19):31540-31553. PubMed ID: 28415561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells.
    Nishizawa S; Hirohashi Y; Torigoe T; Takahashi A; Tamura Y; Mori T; Kanaseki T; Kamiguchi K; Asanuma H; Morita R; Sokolovskaya A; Matsuzaki J; Yamada R; Fujii R; Kampinga HH; Kondo T; Hasegawa T; Hara I; Sato N
    Cancer Res; 2012 Jun; 72(11):2844-54. PubMed ID: 22552285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.
    Wu D; Wang J; Cai Y; Ren M; Zhang Y; Shi F; Zhao F; He X; Pan M; Yan C; Dou J
    J Ovarian Res; 2015 Oct; 8():68. PubMed ID: 26497895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Polo-like kinase 1 (Plk1) in quiescence regulation of cancer stem-like cells of the gastric cancer cell lines.
    Zhu L; Xing S; Zhang L; Yu JM; Lin C; Yang WJ
    Oncotarget; 2017 Jun; 8(23):37633-37645. PubMed ID: 28430578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methyltransferase 1 is essential for initiation of the colon cancers.
    Morita R; Hirohashi Y; Suzuki H; Takahashi A; Tamura Y; Kanaseki T; Asanuma H; Inoda S; Kondo T; Hashino S; Hasegawa T; Tokino T; Toyota M; Asaka M; Torigoe T; Sato N
    Exp Mol Pathol; 2013 Apr; 94(2):322-9. PubMed ID: 23064049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
    Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
    Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
    Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding beta-galactosidase fused to an envelope protein of endogenous retrovirus.
    Takeda J; Sato Y; Kiyosawa H; Mori T; Yokoya S; Irisawa A; Miyata M; Obara K; Fujita T; Suzuki T; Kasukawa R; Wanaka A
    Cell Immunol; 2000 Aug; 204(1):11-8. PubMed ID: 11006013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.
    Francescangeli F; Patrizii M; Signore M; Federici G; Di Franco S; Pagliuca A; Baiocchi M; Biffoni M; Ricci Vitiani L; Todaro M; De Maria R; Zeuner A
    Stem Cells; 2012 Sep; 30(9):1819-30. PubMed ID: 22753241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive cancer stem cell-based vaccination reduces liver metastasis development in a rat colon carcinoma syngeneic model.
    Duarte S; Momier D; BaquƩ P; Casanova V; Loubat A; Samson M; Guigonis JM; Staccini P; Saint-Paul MC; De Lima MP; Carle GF; Pierrefite-Carle V
    Stem Cells; 2013 Mar; 31(3):423-32. PubMed ID: 23193035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.